drugset / Trial / NCT00644982

A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression

NCT00644982

Phase 4 Completed 163 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the comparative efficacy of sertraline versus venlafaxine XR on measures of quality of life.

Timeline

Start
2002-10
Primary completion
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 50 mg Oral
Subject Sertraline Small molecule 150 mg Oral
Comparator Venlafaxine Small molecule 75 mg Oral
Comparator Venlafaxine Small molecule 225 mg Oral